Bionano Genomics Analyst Ratings
Bionano Genomics Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/13/2023 | — | Maxim Group | Downgrades | Buy → Hold | |
08/10/2023 | 713.01% | BTIG | $2 → $10 | Maintains | Buy |
05/25/2023 | 42.28% | EF Hutton | → $1.75 | Initiates Coverage On | → Buy |
05/18/2023 | 62.6% | BTIG | $3 → $2 | Maintains | Buy |
04/24/2023 | 143.9% | BTIG | $3 → $3 | Maintains | Buy |
03/10/2023 | 143.9% | BTIG | → $3 | Maintains | Buy |
02/06/2023 | 631.71% | Oppenheimer | $12 → $9 | Maintains | Outperform |
02/05/2023 | 184.55% | BTIG | $3.5 → $3.5 | Maintains | Buy |
01/05/2023 | 225.2% | Scotiabank | → $4 | Initiates Coverage On | → Sector Outperform |
12/12/2022 | 184.55% | BTIG | → $3.5 | Assumes | → Buy |
07/18/2022 | 875.61% | Oppenheimer | → $12 | Assumes | → Outperform |
04/07/2022 | 469.11% | BTIG | $10 → $7 | Maintains | Buy |
06/16/2021 | 713.01% | BTIG | → $10 | Initiates Coverage On | → Buy |
12/04/2020 | — | Roth Capital | Downgrades | Buy → Neutral | |
09/24/2020 | 1.63% | Ladenburg Thalmann | → $1.25 | Initiates Coverage On | → Buy |
04/08/2020 | 21.95% | Oppenheimer | → $1.5 | Initiates Coverage On | → Outperform |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
11/13/2023 | — | Maxim 集團 | 降級 | 買入 → 持有 | |
08/10/2023 | 713.01% | BTIG | 2 美元 → 10 美元 | 維護 | 買 |
05/25/2023 | 42.28% | EF Hutton | → 1.75 美元 | 啓動覆蓋範圍開啓 | → 購買 |
05/18/2023 | 62.6% | BTIG | 3 美元 → 2 美元 | 維護 | 買 |
04/24/2023 | 143.9% | BTIG | 3 美元 → 3 美元 | 維護 | 買 |
03/10/2023 | 143.9% | BTIG | → 3 美元 | 維護 | 買 |
02/06/2023 | 631.71% | 奧本海默 | 12 美元 → 9 美元 | 維護 | 跑贏大盤 |
02/05/2023 | 184.55% | BTIG | 3.5 美元 → 3.5 美元 | 維護 | 買 |
01/05/2023 | 225.2% | 豐業銀行 | → 4 美元 | 啓動覆蓋範圍開啓 | → 板塊表現跑贏大盤 |
2022 年 12 月 12 日 | 184.55% | BTIG | → 3.5 美元 | 假設 | → 購買 |
07/18/2022 | 875.61% | 奧本海默 | → 12 美元 | 假設 | → 跑贏大盤 |
2022 年 7 月 4 日 | 469.11% | BTIG | 10 美元 → 7 美元 | 維護 | 買 |
06/16/2021 | 713.01% | BTIG | → 10 美元 | 啓動覆蓋範圍開啓 | → 購買 |
12/04/2020 | — | 羅斯資本 | 降級 | 買入 → 中性 | |
09/24/2020 | 1.63% | 拉登堡塔爾曼 | → 1.25 美元 | 啓動覆蓋範圍開啓 | → 購買 |
2020 年 8 月 4 日 | 21.95% | 奧本海默 | → 1.5 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
What is the target price for Bionano Genomics (BNGO)?
Bionano Genomics(BNGO)的目標價格是多少?
The latest price target for Bionano Genomics (NASDAQ: BNGO) was reported by Maxim Group on November 13, 2023. The analyst firm set a price target for $0.00 expecting BNGO to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.
Maxim集團於2023年11月13日公佈了Bionano Genomics(納斯達克股票代碼:BNGO)的最新目標股價。該分析公司將目標股價定爲0.00美元,預計BNGO將在12個月內跌至12個月內(可能下跌-100.00%)。去年有10家分析公司公佈了評級。
What is the most recent analyst rating for Bionano Genomics (BNGO)?
分析師對Bionano Genomics(BNGO)的最新評級是多少?
The latest analyst rating for Bionano Genomics (NASDAQ: BNGO) was provided by Maxim Group, and Bionano Genomics downgraded their hold rating.
Maxim集團提供了Bionano Genomics(納斯達克股票代碼:BNGO)的最新分析師評級,Bionano Genomics下調了持有評級。
When is the next analyst rating going to be posted or updated for Bionano Genomics (BNGO)?
Bionano Genomics(BNGO)的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionano Genomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionano Genomics was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Bionano Genomics的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。Bionano Genomics的最新評級是在2023年11月13日發佈的,因此您應該預計下一個評級將在2024年11月13日左右公佈。
Is the Analyst Rating Bionano Genomics (BNGO) correct?
分析師對Bionano Genomics(BNGO)的評級正確嗎?
While ratings are subjective and will change, the latest Bionano Genomics (BNGO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Bionano Genomics (BNGO) is trading at is $1.23, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的Bionano Genomics(BNGO)評級已下調,目標股價爲0.00美元至0.00美元。Bionano Genomics(BNGO)目前的交易價格爲1.23美元,超出了分析師的預期區間。